• Explore /
  • Poster
  • / <span fontscheme="2">Genome-wide DNA methylation status to predict the efficacy of modified (m)-FOLFOXIRI plus cetuximab as initial treatment for </span><em fontscheme="2">RAS</em><span fontscheme="2"> wild-type metastatic colorectal cancer: A biomarker study of the DEEPER trial (JACCRO CC-13AR).</span>

Genome-wide DNA methylation status to predict the efficacy of modified (m)-FOLFOXIRI plus cetuximab as initial treatment for RAS wild-type metastatic colorectal cancer: A biomarker study of the DEEPER trial (JACCRO CC-13AR).

Abstract Poster

Authors

null

Kota Ouchi

Department of Medical Oncology, Tohoku University Hospital, Sendai, Japan

Kota Ouchi , Akihito Tsuji , Manabu Shiozawa , Takashi Kawai , Hisateru Yasui , Hirofumi Ota , Mitsugu Kochi , Dai Manaka , Hisatsugu Ohori , Toru Miyake , Tatsuro Yamaguchi , Masato Matsuura , Tamotsu Sagawa , Akitaka Makiyama , Kunihiko Wakamura , Masahiro Takeuchi , Wataru Ichikawa , Masashi Fujii , Chikashi Ishioka , Yu Sunakawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Translational Research

Clinical Trial Registration Number

000018412

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 152)

DOI

10.1200/JCO.2024.42.3_suppl.152

Abstract #

152

Poster Bd #

J18

Abstract Disclosures

Similar Posters

First Author: Arndt Stahler

First Author: Jingyuan Wang

First Author: Tanios S. Bekaii-Saab

First Author: Hsiang-Lin Tsai